Author

Ron Hrtska

Mayo Clinic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Akhilesh PandeyiD· 1 shared Douglas Smith· 1 shared Ethan O. PerlsteiniD· 1 shared Éva MoravaiD· 1 shared Frédéric Maxime VaziD· 1 shared Georgia MacDonald· 1 shared Irena Josephina Johanna MuffelsiD· 1 shared Jan Bert van KlinkeniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Akhilesh PandeyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment.

Irena Josephina Johanna Muffels, Kristin A. Kantautas, Georgia MacDonald, Kishore Garapati, Raghavendra Rao Pasupuleti, Rory James Tinker, Rameen Shah, Mathura A. Thevandavakkam, Justin Donnelly, Ron Hrtska, Douglas Smith, Jan Bert van Klinken, Frédéric Maxime Vaz, Akhilesh Pandey, Ethan O. Perlstein, , Éva Morava

This study identifies mitochondrial dysfunction and metabolic impairments in DHDDS-related juvenile parkinsonism and shows that NMN treatment improves symptoms in patient-derived organoids and clinical cases.

medRxiv · Jun 5, 2026 · PreprintGenetic & Genomic Medicine